解析污名与临床精神病高风险青少年心理社会功能的关系:比较症状污名与标签污名何者更强
研究在三个中心招募150名临床精神病高风险(CHR-p)个体,其中113名知晓自身风险者纳入主要分析,比较标签相关污名与症状相关污名的认同率及其与自尊、社会支持丧失和生活质量的关联。结果显示症状相关羞耻感更强而标签相关保密性更高,9项显著关联中8项归因于症状相关污名,即使校正CHR-p症状后仍如此。
要点
- CHR-p个体报告更强的症状相关羞耻感,但标签相关保密性更高。
- 污名与心理社会变量的9项显著关联中8项归因于症状相关污名。
- 校正CHR-p症状后,症状相关污名仍与心理社会变量负相关更强。
核心结论
- 在近期被识别为CHR-p的个体中,症状相关污名较标签相关污名与心理社会变量有更强的负相关。
- 与CHR-p标签相关的保密性高于其症状相关对应项,提示标签相关污名对部分CHR-p参与者可能仍是个问题。
- 为优化这一关键早期干预措施,干预应针对拥有症状的整体「污名化体验」,即所受到的任何有害反应以及参与者受社会影响的对其经历意义的担忧,而不仅是症状本身。
研究设计与样本
- 在三个中心招募CHR-p个体(N=150),主要分析纳入知晓精神病风险的参与者(n=113)。
- 评估两类污名的羞耻相关情绪、保密性和经历歧视三个维度。
- 采用配对样本t检验比较标签相关与症状相关污名的差异,采用回归分析在校正协变量(包括CHR-p症状)后考察与心理社会变量的关联。
主要发现
- 受访者报告更强的症状相关羞耻感,但更多的标签相关保密性。
- 污名与心理社会变量之间的9项显著关联中,8项归因于症状相关污名,即使在校正CHR-p症状后仍如此。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical high risk for psychosis (CHR-p) syndrome enables early identification of individuals at risk of schizophrenia and related disorders. We differentiate between the stigma associated with the at-risk identification itself ('labelling-related' stigma) versus stigma attributed to experiencing mental health symptoms ('symptom-related' stigma) and examine their relationships with key psychosocial variables. AIMS: We compare labelling- and symptom-related stigma in rates of endorsement and associations with self-esteem, social support loss and quality of life. METHOD: We assessed stigma domains of shame-related emotions, secrecy and experienced discrimination for both types of stigma. Individuals at CHR-p were recruited across three sites (N = 150); primary analyses included those who endorsed awareness of psychosis risk (n = 113). Paired-sample t-tests examined differences in labelling- versus symptom-related stigma; regressions examined associations with psychosocial variables, controlling for covariates, including CHR-p symptoms. RESULTS: Respondents reported greater symptom-related shame, but more labelling-related secrecy. Of the nine significant associations between stigma and psychosocial variables, eight were attributable to symptom-related stigma, even after adjusting for CHR-p symptoms. CONCLUSIONS: Stigma attributed to symptoms had a stronger negative association with psychosocial variables than did labelling-related stigma among individuals recently identified as CHR-p. That secrecy related to the CHR-p designation was greater than its symptom-related counterpart suggests that labelling-related stigma may still be problematic for some CHR-p participants. To optimise this pivotal early intervention effort, interventions should address the holistic 'stigmatising experience' of having symptoms, namely any harmful reactions received as well as participants' socially influenced concerns about what their experiences mean, in addition to the symptoms themselves.
引用
- Yang LH, Grivel MM, Blasco D, et al. Parsing stigma's relationship with the psychosocial functioning of youth identified as at clinical high risk for psychosis: evaluating whether symptom stigma or labelling stigma is stronger. Br J Psychiatry. 2024. PMID: 39629604. doi:10.1192/bjp.2024.209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。